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Abstract

Microcephalic osteodysplastic primordial dwarfism type-1 (MODI) is a rare

congenital developmental disorder resulting in patients presenting with microcephaly,
limb abnormalities, and growth retardation. This disease, along with the related Roifman
Syndrome, results from mutations to the gene RNU4atac.1-3 This gene encodes for the
U4atac small nuclear RNA (snRNA) which, along with four other snRNAs (U11, U12,
U5, and U6atac) compose the small nuclear ribonucleoprotein (snRNP) complex called
the minor spliceosome. Responsible for the excision of a subpopulation of introns
(called minor introns), the minor spliceosome is known to play an essential role in
eukaryotic limb development.1-5 However, while mutations in RNU4atac have been
shown to decrease efficiency of minor splicing, a direct role of minor splicing in limb
development has thus far only been implicated. 2 Utilizing a RNU11 conditional knockout
mouse, I demonstrate through a non-U4atac dependent animal model that minor
splicing is required for proper development of the murine limb. Using skeletal analysis I
reveal that minor splicing results in compromised development of the mouse limb, and
that the severity of this developmental disruption increases along the proximodistal axis.
Additionally, utilizing TUNEL assays alongside immunofluorescence I demonstrate that
that minor splicing may play a role in maintenance of the proliferating progenitor cell
population within the developing mouse limb.

v

Introduction
Microcephalic osteodysplastic primordial dwarfism type 1 (MOPDI) (OMIM
210710), is a rare developmental disorder which has been reported in less than 50 cases
world-wide.

Individuals born with this disease suffer from severe developmental

abnormalities including disruption of brain formation (microcephaly), defects in long bone
growth and patterning (osteodysplasia), and general intrauterine growth retardation
defined as primordial dwarfism. The prognosis of MOPDI patients is poor, with the
majority of confirmed cases dying within their first year of life. In 2011 it was reported that
patients suffering from MOPDI possessed either one or multiple mutations in the gene
RNU4ATAC, which encodes for the U4atac small nuclear RNA (snRNA). U4atac is an
essential component of a small nuclear ribonucleoprotein (snRNP) complex called the
minor spliceosome.
In all eukaryotes, genes are segmented into coding regions called exons and noncoding regions called introns. In order for these segmented genes to be properly
expressed, their initial transcripts must undergo several levels of processing before they
can be exported from the nucleus to the cytoplasm. In addition to modifying the transcripts
via capping and polyadenylation to allow for transport and prevent degradation, the
introns of eukaryotic pre-mRNA transcripts must be spliced out and the exons ligated
together. The vast majority of this splicing is accomplished by a snRNP complex known
as the major spliceosome. Through the interaction of multiple snRNAs and hundreds of
associated proteins, this complex is able to identify the boundaries of introns. It is then
capable of binding to specific interacting sites, or consensus sequences, within these
introns, and by undergoing a series of structural modifications, conducts two trans1

esterification reactions which simultaneously remove the bound introns and ligate
together flanking exons. This mechanism of mRNA splicing is an essential part of
eukaryotic RNA processing, and is entirely based around the ability of the major
spliceosome to identify specific consensus sequences within the introns. However, there
exists a small population of genes which contain introns possessing divergent consensus
sequences that cannot be recognized by the major spliceosome complex. These introns
must therefore undergo an alternative method of splicing through the use of a unique
splicing snRNP complex known as the minor spliceosome.
Alternative splicing allows for a relatively small number of genes (20,000-25,000
in humans) to encode for a much larger range of final protein products (>250,000).
Additionally, intron retention can regulate gene expression through pathways such as
non-sense mediated decay (NMD). It has been suggested that the lower activity of the
minor spliceosome compared to its major counterpart causes inefficient splicing of minorintron containing genes. Subsequent intron retention could generate a bottleneck, thereby
regulating minor intron-containing gene (MIG) expression. 6 While the precise role of minor
splicing is not yet known, it has been demonstrated to be required for development in
eukaryotes which possess minor introns, including humans. 1-5
My thesis work seeks to understand what role minor splicing plays in development
by investigating how the loss of this cellular process results in limb developmental defects
in mice. I propose that minor splicing is required for normal maintenance of progenitor
cell populations in the developing limb, and that loss of minor splicing results in a
decrease of early progenitor cell populations through a combination of cell death and an
exiting of cells from cell cycle. I will utilize a mouse knock-out engineered to conditionally
2

disrupt expression of the gene RNU11 which encodes for the U11 snRNA, an essential
component of the minor spliceosome. Through a combination of post-natal skeletal
comparisons, I will determine if long bone growth is disrupted in mouse limbs lacking U11
expression.

I

will

also

use

a

combination

of

In

situ

hybridization

and

immunohistochemistry techniques to investigate whether any difference in the limbs of
U11 mutants can be attributed to a shift in progenitor cell proliferation or survival.
RNA Splicing and Minor Splicing
The vast majority of eukaryotic genes are segmented into exonic (coding) and
intronic (non-coding) regions. In order for those genes to be expressed and their mRNA
transcripts to be accurately translated to a final protein product, the noncoding introns
must be removed through a process known as splicing. RNA splicing is the result of
interactions between the pre-mRNA transcript and a snRNP complex known as the
spliceosome. Most eukaryotic introns undergo splicing by way of the major spliceosome,
which consists of five small nuclear RNAs (snRNAs): U1, U2, U4, U5, U6; as well as
hundreds of associated proteins. During transcription of the nascent pre-mRNA, the major
spliceosome associates with specific consensus sequences within the intron and
conducts a series of transesterification reactions which results in the ligation of the 5’ and
3’ exons and the simultaneous generation and excision of an intron lariat structure (for
full review see ref. 7-9).
The three sites required to direct activity of the major spliceosome are known as
the 5’-splice site (5’SS), the branch-point sequence (BPS), and the 3’-splice site (3’SS).
These sites consist of characteristic nucleotide sequences and can be annotated as 5’AG/GTRAGT-3’ (where R is a purine), 5’-YUNAY-3’ (where Y is C or T), and 5’-NCAG/G3

3’ (where N indicates any nucleotide), respectively. 10-13 The general activity of the major
spliceosome is schematized in Figure 1A. Splicing begins with the binding of the U1
snRNA and its associated proteins to the 5’SS through complementary base paring of the
U1 snRNA and the nascent transcript. The branch point of the intron is then bound by the
U2 small nuclear ribonucleoprotein particle (snRNP) through partial complementarity with
the U2 snRNA. The major spliceosome complex is completed by the inclusion of a trisnRNP particle consisting of the U4, U5, and U6 snRNPs. During the splicing process, a
specific adenosine residue known as the branch point is displaced due to incomplete
complementarity between the BPS and the U2 snRNA. This allows the first
transesterification reaction to take place between the branch point adenosine and the
5’SS, forming the intermediate intron lariat structure. RNA splicing concludes with the
ligation of the 5’ and 3’ exons through a second transesterification reaction, and the
simultaneous release of the intron lariat.7-9

4

Figure 1: Schematic of eukaryotic mRNA splicing. A) The major splicing pathway and B) minor splicing
pathways are compared above. Essential RNA-RNA binding regions are diagramed in highlighted boxes
comparing how the secondary structures formed are similar in both major and minor splicing. Colored
circles indicate splicing snRNP particles while the secondary structures of the major and minor snRNAs are
displayed within these circles. Both splicing processes are similar, except in that the U11 and U12 snRNPs
of the minor spliceosome bind to their consensus sequences as a di-snRNP, rather than individually as
occurs with their major counterparts (U1 and U2).

5

While major splicing accounts for over 99% of eukaryotic splicing, there exists an
extremely small number of introns (<0.5%) which contain consensus sequences that
significantly diverge from the majority of introns. The divergence prevents this minor
population of introns from being processed by the major spliceosome. A second splicing
pathway has therefore evolved to specifically target this intron subpopulation, and was
appropriately named the minor spliceosome. Consisting of four unique snRNAs called
U11, U12, U4atac, and U6atac, the minor spliceosome also contains the U5 snRNP which
it shares with the major spliceosome. The 5’SS, BPS, and 3’SS of minor introns can be
described as 5’-/(R)TATCCTTT-3’, 5’-TTCCTTRAY-3’, and 5’-YAG/-3’ respectively. 10,12,14
However, despite their divergence from the consensus sequences of major introns,
processing of minor introns by the minor spliceosome is very similar to that of its major
counterpart, and is schematized in Figure 1B. While the biomechanical processes
between the major and minor splicing pathways are similar, a major difference is the fact
that unlike U1 and U2, U11 and U12 of the minor splicing pathway exist as a di-snRNP
particle, requiring simultaneous targeting of the 5’SS and BPS.
Despite the fact that minor introns compose such a small part of the overall intron
population, they are conserved amongst eukaryotes and have been identified in every
major eukaryotic super group.15,16 The extensive proliferation of this intron subpopulation
throughout the Eukaryota domain suggests that minor splicing emerged early on during
eukaryotic evolution. Despite the rarity of minor introns, loss of minor splicing can have
severe developmental repercussions in a wide variety of organisms, giving insight as to
the reason for its retention throughout evolution.
6

Research conducted by Kim et al. in the plant Arabidopsis thaliana found that when
minor splicing was disrupted, plants were either aborted early in development in knockout mutants, or else suffered severe developmental defects in knock-down experiments. 4
Additional studies in Arabidopsis, Drosophila melanogaster and Danio rerio have yielded
similar results demonstrating that minor splicing is essential for development in almost all
eukaryotes, including humans.1-3,5,17-18
Since its initial identification as a minor splicing-associated disease, it has been
found that individuals with MOPDI suffer from both characteristic CNS developmental
defects, as well as a great deal of skeletal malformations including platyspondyly, short
iliac wings, short and flat long bones, and flat/irregular acetabular roofs. 19,20 With the
identification of RNU4atac mutations as the cause of this disease, two groups identified
over seven different mutations capable of resulting in this disease (figure 2). Splicing
assays focusing on these identified mutations demonstrated that disruption to U4atac
could result in over a 90% reduction of minor splicing efficiency. Such results for the first
time allowed the inference that minor splicing could play an essential role in human
development.1,2

7

More recently, disruption of minor splicing has been implicated in another human
developmental
disease,

known

Roifman
(OMIM

as

syndrome
616651).

In

2015, Merico et al.
demonstrated

that

patients suffering from
this congenital disorder
also
mutations
RNU4atac

possessed
in

the
gene

(figure 2).3 Classified
as a separate disorder

Figure 2. Location of disease related U4atac Mutations. The
locations of Rnu4atac mutations which have been associated with
developmental defects in both MOPDI and Roifman Syndrome are
marked, allowing visualization fo what secondary structures they
might impact. Regions of the U4atac snRNA which have been shown
to be essential for splicing are highlighted in yellow.1-3

from MOPDI, Roifman syndrome is characterized by several distinct features including
antibody deficiency and retinal dysplasia. 21-24 However, both MOPDI and Roifman
syndrome share several symptoms including disrupted cognitive development, growth
retardation, and skeletal dysplasia.3,21-24 While it is curious that mutations in the same
gene can result in completely separate diseases, the fact that specific developmental
defects are at least partially shared between both MOPDI and Roifman patients is
informative. In particular, the shared cognitive delays and osteodysplasia common across
in both of these diseases indicate that minor splicing plays an essential role in both CNS
and skeletal development. While work has already been conducted focusing on the role
8

of minor splicing in brain development, its function in the development of the skeletal
system (particularly in regards to limb growth) has yet to be investigated. 25
The Limb as a Model System
The limb has long been used as a paradigm for studying organogenesis and
patterning during development. As a system, the limb allows for the simultaneous study
of multiple tissue types including muscle, nervous, and bone. Additionally, unlike other
systems, in many animals limbs are not essential for embryonic survivability. As such,
major or even complete disruption of the limb through either genetic or mechanical
manipulation will not cause death during gestation, thus allowing for thorough
investigation of the initiation of its growth throughout development.
Development of the limbs in mice is staggered, with growth of the forelimb
initiated at embryonic day 9.5 (E9.5) and hindlimb growth beginning approximately a half
day later at E10.26 Limb development starts with the expansion of the mesenchyme tissue
within the lateral plate mesoderm (LPM). This expansion occurs only at specified
regions along the anterior-posterior axis of the developing embryo, known as the limb
field. In mice, these limb fields are found adjacent to specific somite ranges with fore- and
hindlimbs forming between somites 13-17 and 27-31, respectively. 27 After the initiation of
growth at these pre-specified positions, the limb itself develops rapidly with the three
skeletal domains of the limb (stylopod, zeugopod, and autopod) finishing their patterning
by the end of E14 (figure 3A).
Before growth of the limb can occur, the limb fields must first be established at the
specified somite regions. While the precise signals involved in this limb field preparation
9

are still under investigation, it has been suggested that limb field establishment relies on
expression of retinoic acid (RA) from within the trunk mesoderm. This role of RA was
initially proposed due to investigations in chicks which found that insertion of RA-soaked
beads could result in the initiation of ectopic limb growth.28 Further studies confirmed that
if RA synthesis was disrupted by way of Disulphiram addition prior to limb outgrowth, loss
of RA was capable of abolishing limb development. 29 The possibility of RA acting as the
direct effector of limb bud initiation is unlikely. While mouse knockouts of retinaldehyde
dehydrogenase 2 (raldh2), the enzyme responsible for RA synthesis, do result in failed
initiation of forelimb development; rescued limb development through a low RA diet
displayed no RA in the LPM. This would indicate that while RA is essential for limb
development, it is likely the initial role of RA lies in establishing the limb field, rather than
in the initiation of limb growth.30-32
Once the limb fields have been established the first stage of limb growth is the
formation of the limb bud, a small ectodermal sack which encompasses the proliferating
mesenchymal tissue. Formation of this bud is driven by additional signals from the LPM,
believed to consist primarily of fibroblast growth factors (FGFs). FGF10, a paracrine
factor secreted by mesenchymal cells of the LPM, is thought to be the most likely
candidate for initiation of limb bud growth from the established limb field. Whole-mount in
situ hybridization of FGF10 in chicks has revealed that FGF10 is initially expressed
throughout the LPM before becoming restricted to the prospective limb mesoderm and
eventually the limb mesenchyme.33 Additionally, ectopic expression through FGF10
soaked beads results in initiation of ectopic limb growth by inducing FGF8 expression in
the overlying ectoderm.34
10

After the initial induction of the limb bud, the mesenchyme cells of the limb
establish an essential signaling center in the overlying ectodermal tissue called the apical
ectodermal ridge (AER). The induction of this ectodermal signaling center is believed to
be the result of interactions between Wnt/β-Catenin and FGF10. Within the mesenchyme
of the limb bud, Wnt/β-Catenin signaling is required for expression of FGF10. This was
demonstrated through the implantation of cells engineered to express Wnt-2b into chick
mesenchyme. The implanted cells were capable of causing FGF10 expression within the
mesenchyme, eventually resulting in the formation of ectopic limbs. 35 FGF10 derived in
the limb bud mesenchyme is capable of inducing expression of FGF8 in the overlying
ectoderm. This induction has been demonstrated through misimpression experiments in
the chick to act through an intermediary of Wnt3a.36 FGF8 produced from the now formed
AER is then capable of inducing continued FGF10 expression within the limb bud
mesenchyme, generating a feedback loop which assists in maintaining a functioning
AER.35-38
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Figure 3: Refinement of limb developmental models. A) The skeletal elements of the mouse limb. The
stylopod region contains the proximal long bone (humerus, femur), while the zeugopod forms the distal long
bones (radius/ulna, tibia/fibula) and the autopod generates the wrist (carpals, tarsals), palm (metacarpals,
metatarsals, and digits (phalanges). B) The progress zone model sought to explain the results of AER
removal experiments conducted in the chicken limb bud. It was hypothesized that the AER acts as a timekeeping mechanism, dictating proximal to distal cell fate (colored regions) of the underlying mesenchymal
cells based on duration of exposure to AER signaling within the progress zone (the labeled circular region).
C) Molecular analysis of the developing limb bud gave rise to the Two Signal model of development . This
model proposes that early in development the proximal region of the limb is patterned by retinoic acid (RA)
expression while the distal regions are specified by exposure to FGF signaling from the AER. Mesenchyme
receiving input from both signaling regions forms the interior zeugopod region. D) The differentiation front
model attempted to reconcile earlier proposed concepts of limb patterning. This model suggests that
patterning of proximal to distal regions are set early in development, but progenitor cells are kept in an
undifferentiated state as long as the within the differentiation front. Exiting of this region causes
differentiation and allows for the expansion of the already specified limb regions.
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With the establishment of the limb bud, proximal-distal growth as well as anteriorposterior patterning within the limb is driven by a complex network of signals between
multiple regions within the limb itself (figure 3). Several models have been proposed to
describe limb growth beginning with early seminal work by Saunders in 1948. Using
chicken embryos, Saunders removed the most distal region of the developing chick limbs
at progressively later time points. It was found that earlier removal of this region
(containing the AER) would result in more proximal disruption of limb growth. 39 Building
off of these experiments Wolpert et al. proposed the progress zone model of limb
development (figure 3B). Postulating a time-keeping role for the AER, the progress zone
model of limb growth suggests that signals secreted from the AER maintain the
proliferative ability of mesenchyme cells in the distal end of the developing limb known as
the “progress zone.” Cells which lie within this zone of influence are allowed to proliferate
while remaining in an undifferentiated state. Their eventual proximal-distal fate is
determined temporally, based on what time in development they exit the migrating
progress zone. Those cells which leave the AER’s influence early become components
of proximal structures (scapula/pelvis, humerus/femur) while those which travel within the
zone until later in development take on more distal identities (ulna/tibia, radius/fibula). 39,40
While this model succeeded in describing the results of AER removal experiments, the
progress zone cannot be easily reconciled with more recent genetic experiments.
In the investigation of the AER signaling in limb development, it has been shown
that loss of the AER can be rescued through expression of FGF molecules, identifying
them as the primary signaling molecules of the AER (AER-FGFs). 41-44 While four of these
FGF signaling molecules have been found to be expressed specifically in the AER (FGF4,
13

FGF8, FGF9, and FGF17), FGF8 is both the earliest present, as well as the only FGF
expressed throughout the entirety of the AER.45-48 When a knockout mouse lacking FGF8
was generated, limb growth of these mice was severely stunted, and proximal skeletal
elements failed to form correctly.49 Additional genetic analysis and fate mapping
experiments by groups such as Mariani et al. and Dudley et al. have shown through a
combination of genetic analyses and fate mapping that the proximal-distal axis of the
developing limb is laid out early on in development. Additionally, these specified
progenitor pools expand sequentially in proximal to distal direction. 48,50 Observations such
as these run counter to the proposal that the AER plays a permissive time-keeping role
in development. Instead these experiments seemed to suggest a far more active role for
the AER in proximal-distal patterning; necessitating a new model for limb development.
Work conducted using the chick limb has given some evidence that retinoic acid
is capable of informing proximal identity in the developing limb. 51In addition, the same
experiments which demonstrated the necessity of updating the progress zone model have
given strong evidence to the role which FGF8 and the AER play in establishing proximaldistal limb identity.48 The two signal/early specification model proposes that the
antagonistic signaling between RA and AER-FGFs results in the establishment of the
proximal-distal axis of the limb (figure 3C). This model in turn coincides with the mapping
of specific transcription factors correlating to specified regions of the developed limb.
Retinoic acid induces expression of Meis1 and Meis2 within the stylopod region while
FGFs from the AER result in expression of homeobox A11 and A13 (Hoxa11/Hoxa13) in
the more distal regions of the zeugopod and autopod fated cells. 51,52 While this two-signal
system works to reconcile the early specification problem found in the progress zone
14

model, it too requires further modification. In particular, RAs role as both the initiator of
limb bud growth as well as the establishing factor of proximal cell fate is a matter of
continued further study. Loss of retinaldehyde dehydrogenase 2 (Raldh2), an enzyme
required for RA synthesis in mice, leads to disruption of the initiation of limb bud growth.
This effect can be rescued by the application of exogenous retinoic acid, giving support
to its role in establishing the prospective limb field.30 However in studies conducted on
mice in which the limb bud initiation was rescued using RA, it was shown that RA signaling
may take place through inhibition of FGF8 (an AER-FGF) in proximal mesenchyme rather
than through RA acting as a polarizing factor itself. 32
In an attempt to reconcile the aforementioned models in 2007 Tabin proposed the
differentiation front model (figure 3D). This model proposes that the mesenchyme of
the early limb bud is pre-specified to form proximal structures of the limb. However, this
proximal “default” can be modified by FGF signaling from the AER which can in turn instill
distal cell fates. The FGF signals are able to maintain the underlying distal mesenchyme
in an undifferentiated proliferating state. The border region between proximal determined
cells and the proliferating mesenchyme is defined as the differentiation front, which
continues to move distally as the limb expands.53
While the precise model to describe limb patterning and growth is an area of
continuing study, several aspects of limb growth have been well investigated, particularly
in regards to anterior-posterior patterning in the limb, as well as limb expansion during
development. Early work conducted through transplantation experiments of chick limb
mesenchyme to ectopic regions of the limb bud revealed the existence of an organizer
within the posterior mesenchyme of the developing limb bud.
15

This

organizer,

known as the zone of
polarizing activity (ZPA),
was shown to be the
primary

center

establishing

of

anterior-

posterior identity within the
limb through the paracrine
signaling molecule sonic
hedgehog (SHH). Loss of
SHH expression through
genetic inactivation results
in loss of posterior digits
while ectopic expression of
SHH

through

transplantation of SHHexpressing cells to the
anterior

region

of

the

developing limb results in
mirror-image

digit

Figure 4. ZPA Formation and Establishment Of SHH-GREM1FGF feedback Loop. A) The French-flag model of development
patterning proposes that a signaling center releases a concentration
dependent signaling molecule (a morphogen) which is then capable
of establishing a developmental pattern based on the concentration
gradient of the molecule. Such a model has been proposed for SHH
signaling to induce A-P patterning within the developing limb. B)
Initiation of the SHH generating ZPA is the result of HAND2 and
‘HOXD from the limb mesenchyme. Establishment of HAND2 and
HOXD may rely on RA while localization of the ZPA to the posterior
limb region results from Gli3 repressor activity. C) Maintenance of
both the AER and ZPA require a signaling interaction between the
two regions. This interaction is mediated by inhibition of BMP4
activity by GREM1 in the limb bud mesenchyme. Shh from the ZPA
maintains GREM1 expression. This in turn prevents BMP activity
from terminating FGF signaling within the AER, allowing the
continued FGF feedback required to maintain the ZPA.

duplication.54,55 This paradigm of gradient patterning was described by Wolpert as a
French-flag model of development wherein AP identity could be determined based on a
cell’s exposure to a gradation of SHH (figure 4A).56
16

Initiation and localization of the shh-expressing ZPA has been shown to be
dependent on the interaction between several signaling factors (figure 4B). Two of the
leading initiators of ZPA formation are believed to the 5’- located Hoxd (5’HOXD) and the
heart and neural crest derivatives 2 (HAND2) genes, the loss of which disrupt shh
expression in the developing limb.57-60 Initiation of these genes is believed to possible rely
on RA signaling from the trunk mesoderm, while their restriction to the posterior region of
the developing limb bud is carried out by activity of GLI3 activity (figure 4B).30,49,61
Beyond their roles of anterior-posterior and proximal-distal pattering, the
maintenance of both the ZPA and AER are linked to one another in a complex feedback
loop. The importance of AER-ZPA interaction was first confirmed by the fact that after
AER removal, both continued limb outgrowth and Shh expression could be maintained by
the application of FGFs.62,63 A summarized schematic of the SHH-GREM1-FGF signaling
loop is schematized in figure 4C which displays the interactions between the ectodermal
AER, the posterior ZPA, and the mesenchyme of the developing limb itself. Once the AER
and ZPA have both been induced the ZPA requires continued FGF input from the AER in
order to maintain SHH expression. 62,63 The AER is capable of maintaining this FGF
expression by way of an intermediary signaling pathway within the limb mesenchyme
consisting of gremlin 1 (GREM1), a bone morphogenetic protein (BMP) antagonist and
BMP4. The importance of GREM1 as an intermediary in ZPA-AER signaling was
confirmed through inactivation of gremlin 1 in mice, resulting in both a halt of distal limb
bud expansion, as well as disruption to AP pattering. 64 In normal mice SHH is able to
maintain GREM1 expression which in turn, through antagonistic action against BMP4,
allows for the continued expression of FGF’s from the AER. It is this SHH-GREM1-FGF
17

feedback loop which allows for the continued proximal distal expansion, as well as the
AP patterning, of the developing limb.
Taking into account the complexity of the interactions between signaling centers
which must occur for proper limb development to take place, it is perhaps not surprising
that the limbs are one of the main systems impacted by disruption of minor splicing in
MOPDI patients. Is minor splicing required for normal limb development, or is the
osteodysplasia observed in patients with mutations in the U4atac gene a result of an asof-yet unidentified disease pathway? Until recently, the 90% reduction in minor splicing
efficiency described due to U4atac mutations have only been correlative to diseases such
as MOPDI and Roifman Syndrome. Minor splicing itself has not yet been demonstrated
to be the direct cause of the limb defects reported in patients with U4atac mutations.
However, the recent generation of a U11 conditional knock-out mouse line gives us a
novel approach of investigating the direct impact of minor splicing on limb development.
With these mice I plan to test whether minor splicing is indeed the direct cause of the limb
defects found in MOPDI patients. Additionally, in this thesis I demonstrate that disruption
of cell cycle within the proliferating mesenchyme of the developing limb could describe at
least some of the symptoms reported in MOPDI and Roifman. Finally, I will seek to
describe how minor splicing might fit into currently proposed models of limb development.

18

Materials and Methods
Mouse Genetics
The Rnu11 conditional knockout mouse used for this project was generated with
assistance from the University of Connecticut Health Center. An independent targeting
construct was generated for each loxp site flanking the RNU11 on chromosome 4. The 5’
loxp site construct was engineered using a PGK-Neo cassette flanked by loxp sites, which
was then targeted into 129X1/SvJ mouse embryonic stem (ES) cells. G418-mediated
positive selection was used to confirm successful targeting and was followed by negative
selection with FIAU. When a positive clone was achieved, removal of the Neo cassette
was conducted via transient transfection of cre. The 3’ loxp site construct containing a Frt
site-flanked PKG-Neo cassette and one loxp site downstream of the 3’ Frt site, was
targeted into the positive clone. G418 and FIAU were again used to identify clones that
underwent successful homologous recombination. This ES cell clone was then injected
into C57BL/6 blastocysts to generate a chimaera. Germline transmission and ablation of
the Neo cassette was verified by introducing germline Flp recombination. Proper loxp site
placement in the resulting mouse line was confirmed by PCR. Prrx1-cre was bred into the
Rnu11Fl/Fl to achieve a conditional knockout line to target Rnu11 for removal in the
developing limb mesenchyme.
P0 Skeletal Preparations
P0 mouse pups were harvested, anesthetized and euthanized via cooling. Skin
and viscera of the pups were removed using forceps. To remove epidermis from paws,
carcasses were scalded in 65OC water for 45 seconds. Pups were then fixed in 4%
19

paraformaldehyde overnight at 4OC. After approximately 12hrs pups were then switched
to 95% EtOH and allowed to sit overnight at 4 OC. Initial cartilage staining was conducted
using alcian blue (Sigma A3157) in a solution consisting of 95% EtOH and 25% acetic
acid. After initial staining, skeletons were washed in 95% EtOH and treated in 2% KOH
for 2-3 days until mostly clear. After KOH clearing, ossified tissue was stained for 1-2
days in a solution of 0.015% Alizarin red (w/v) and 1% KOH. Clearing was conducted in
1% KOH/20% Glycerol for 2 days followed by a final clearings step in 1% KOH until
skeleton could be cleanly imaged. After initial imaging skeletons were stored at 4 OC in a
1:1 ratio of glycerol and 95% EtOH.
PCR for U11 riboprobe preparation
Mouse tissue was harvested from various developmental stages and the total RNA
was collected from the retinal tissue utilizing Tri-Zol as described by the manufacturer.
cDNA was then generated from 5μg of the collected RNA. 50 ng of oligo dT primers and
300 ng of hexamers were mixed with total RNA and incubated for 10 minutes at 65 OC.
The mixture was then set to incubate further for 15 minutes at room temperature. 1μl of
reverse transcriptase (Roche), 2.5mM dNTPs, and 1 μl of RNase inhibitor (Roche) were
then added to the reaction mix and left to incubate at 42 OC for 1 hour. RT-PCR was then
conducted utilizing the following primer pairs: forward Rnu11 (5’-AAA GGG CTT CTG
TCG TGA GTG GC-3’), reverse Rnu11 (5’-CCG GGA CCA ACG ATC ACC AG-3’). The
PCR protocol used for the PCR was 30 cycles of 95OC for 30 seconds, 65OC for 30
seconds, and 72OC for 2 minutes.
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pGEMT Cloning and Sequencing
PCR products were visualized on a .9% agarose gels. The agarose gels were
mixed with ethidium bromide (EtBr) for visualization of DNA by florescence of EtBr under
UV light. The resulting band for U11 coding was excised using razors and isolated by Gel
Extraction Kit (Qiagen), using the protocol described by the manufacturer. 1 μl of the gel
extraction product was added to a solution containing .5 μl of linearized pGEMT (cut with
EcoRI), 1 μl of T4 ligase, 1 μl 10x ligase buffer, and 6.5 μl ultra-pure water. The ligation
reaction was then left to incubate at 4OC overnight. 50 μl of DH5-α cells were transformed
by adding 3μl of the pGEMT ligation mixture to the cells, and then allowing them to sit on
ice for 10 minutes. A 30 second heat shock at 42OC was then administered to the cells
before they were allowed to sit on ice once more for 10 minutes. The transformed DH5α cells were then plated onto LB-AMP. Surviving colonies were then amplified and sent
for sequencing.
In situ Probe Preparation
To prepare a probe for mouse in situ hybridization, a pGEMT plasmid containing
the U11 sequence was used as a template for PCR amplification using primes
complementry to the T7 and Sp6 sites that exist in pGEMT and flank the U11 insert. The
linear fragments that resulted from PCR amplification were then seperated on .9%
agarose gel, and the band containing U11 was extracted using a Gel Extraction Kit
(Qiagen). This gel extrated product was then used as a templae for Sp6 RNA polymerase
to generate an antisense riboseprobe. 2 μl of the gel extraction product were combined
with 2 μl 10x Sp6 buffer (Roche), 1 μl RNase inhibitor (Roche), 1 μl Sp6 RNA polymerase
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(Roche), 2 μl of 10x Nucleotide DIG-labeling Mix (Roche), and 12 μl of DEPC-treated
water. The reaction mixture was incubated for 2 hours at 37 OC. The transcription reaction
was then treated with 1 μl of DNase and left to incubate at 37 OC for 15 minutes. The
resulting RNA probes were then precipitated using ethanol and resuspended in a mixture
containing 10 μl DEPC-treated water and 90 μl DI formamide.
Whole-mount In situ Hybridization
Embryos were harvested at embryonic days 9, 10.5, and 12. Embryos were initially
fixed in 4% PFA/PBS overnight at 4OC. After fixing embryos were washed in PPBS mixed
with 1% TWEEN (PBT) and dehydrated using a graded methanol/PBT series (25%, 50%,
75%, 100%). Embryos were then stored in 100% methanol until used. For WISH embryos
were rehydrated in a 75%, 50%, 25% methanol/PBT series. They were then washed with
PBT at room temperature. Bleaching of embryos was conducted in 5% H2O2 for 1 hour at
room temperature. Embryos were then washed with PBT and treated with proteinase K
for 6 to 15 minutes ranging with age of embryo. Proteinase K was inactivated using
glycine and embryos were washed before re-fixing in 4% PFA and 0.2% glutaraldehyde
in PBT. Final washes were conducted in PBT and the embryos were hybridized with the
U11 riboprobe at 70OC overnight. After hybridization embryos were washed several times
in SSC solutions to remove unbound probe and blocking was conducted with 10%
HISS/0.1% Boerhinger Mannheim blocking reagent in in TBST. Embryos were incubated
α-DIG-AP (Roche) at 1:2500 overnight at 4OC. Embryos were then washed in TBST for a
day before development using BCIP and NBT.
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Section In situ Hybridization
The in situ hybridization of the U11 was performed with 20 μm sections of mice
limbs from various developmental time-points. The tissue was fixed using 4% PFA and
washed using PBS mixed with .1% TWEEN. The cryosections were then incubated for
10 minutes at room temperature in 1 μg/ml PK (Roche) in PBS. All slides were then
acetylated at room temperature for 10 minutes. After words slides were hybridized with
3μl of in situ probe in 150 μl hybe solution overnight at 65 OC. The retinal sections were
then washed in SCC, treated with RNase A, and incubated with α-DIG-AP (Roche) at
1:2500 concentration in 5% HISS/MABT. The sections were then developed using BCIP
and NBT before being mounted using gelvatol.
Immunofluorescence
25 μm cryosections of mice limbs were hydrated in PBS at room temperature
before being blocked for 1 hour at room temperature using a blocking buffer consisting of
0.2% BSA, 0.1% Triton-X 100, and 0.02% SDS in PBS. These limb sections were then
incubated at 4OC in primary antibodies diluted in blocking buffer. The primary antibodies
used for E14, E12, and E11 were mouse anti-Ki67 (1-300 dilution), rabbit anti-Ph3 (1-300
dilution), and Rabbit anti-Sox9 (1-300 dilution). The following day cryosections were
washed with blocking buffer for 3 hours with changes in buffer every 10 minutes. They
were then incubated overnight at 4OC with secondary antibodies of either Donkey antimouse, or donkey anti-rabbit (1-500 dilution). The final day sections were washed with
blocking buffer for 3 hours with changes in buffer every 15 minutes. DAPI was added to
the blocking buffer for E12 electroporation sections to stain cell nuclei. All sections were
23

then washed three times with PBS and mounted using ProLong Gold Antifade reagent
before being imaged using confocal microscopy.
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Results
U11 is expressed in developing limbs and is lost in Prrx1-cre driven cKO
To confirm that the minor splicing snRNA U11 is indeed expressed in MOPDI and
Roifman syndrome affected tissue, whole mount In situ hybridization (WISH) was
conducted using a RNA probe complimentary to U11. At E9 growth of the forelimb has
just initiated and as development of the hindlimb is delayed by half a day, it is not yet
visible. At this time,
alkaline
phosphatase (AP)
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U11 is expressed
throughout
majority

the
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embryo,
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Figure 5: U11 Whole-Mount In Situ Hybridization. A) Alkaline
phosphatase staining shows localization of U11 expression within the
developing embryo at varying time points in limb development. Yellow
arrows mark forelimb outgrowth. Green arrows mark hindlimb outgrowth.
AP staining demonstrates U11 is expressed in both limbs throughout
development. B) Closer inspection of the forelimb bud shows that U11 is
expressed throughout the limb, and expression increases by E11. At E13
U11 expression can be seen through the entire limb. Arrows indicate
cartilage condensations’ which will give rise to boney elements of the digits.

and the forelimb bud have high levels of Rnu11 expression (figure 5A). By embryonic
day 10 both the fore- and hindlimb are clearly present, with U11 expression visible in both
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of the developing limb buds.
This expression continues
into E11 where the limbs are
perhaps

the
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expressing region of Rnu11.
By E12 the limb paddle has
completely formed with both
limbs

continuing

to

demonstrate high levels of
U11. In the limb bud itself, AP
staining

appears

uniform

throughout from E9 to E11.
By E13, U11 expression can
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which will eventually form the

Figure 6: Gross Phenotype of U11 cKO Mutants. A/E) Fullbody comparison of wild-type P0 pup and U11 cKO littermate.
Severe disruption of development can be observed in both foreand hindlimb regions. B/F) Magnified image of wild-type and
mutant forelimb reveals complete loss of gross anatomical
structure in P0 mutant. C/G) Comparison of wild-type and cKO
hindlimb reveals that while there is a decrease in overall size of
the mutant hindlimb, patterning appears patterning appears
unaffected. P0 mutant hindlimb. D/H) P0 U11 cKO mice develop
an encephalocele, likely due to Prrx1-driven loss of U11 in the
craniofacial mesenchyme. I/J) Skeletal staining was conducted
to analyze how loss of U11 in the limb bud mesenchyme
impacted skeletal development by P0. Alcian blue (blue stain)
was used to stain cartilage while alizarin red (red stain) was
employed to mark calcium, allowing for identification of ossifying
bony elements.

digits of the autopod (figure 5B).

Loss of U11 Results in Major Disruption of Mouse Limb Development by P0
To generate a limb specific Rnu11 cKO mouse, Rnu11Wt/Fl::Prrx1-cre mice were
crossed with Rnu11Fl/Fl. This cross resulted in mutants easily discernable from wild-type
littermates due to major disruption of both the fore- and hindlimbs (figure 6A/E). Though
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limb development was impacted, all mutant pups were born alive and have survived up
to post-natal day 6 (data not shown). In addition to limb defects, mutants were born with
an encephalocele in the posterior region of the skull, likely a result of Prrx1-driven U11
loss in craniofacial mesenchyme (figure 6D/H).
Disruption of limb development at P0 is most severe in the forelimb. In both wildtype and mutant pups, the stylopod cannot be viewed as it develops internally. However,
while the zeugopod and autopod are clearly identifiable in wild-type littermates, no
zeugopod or autopod regions were discernable in mutants. The only gross anatomical
structure visible was a small stump in the location of the forelimb. While it is possible that
this structure could represent either an undeveloped zeugopod or autopod, there are no
signs of individual digits that would allow for confirmation of this identification (figure
6B/F). The hindlimbs of these mutants appear to be fully patterned with the zeugopod
and autopod identifiable in both wild-type and mutant pups (figure 6C/G). However, a
severe difference in size between wild-type and mutant hindlimbs demonstrates that
development is clearly influenced by loss of U11.
To more accurately determine what skeletal defects might give rise to the
phenotype observed, I conducted skeletal preparations of both wild-type and mutant pups
at P0. Alcian blue was employed to stain acidic polysaccharides allowing for the
visualization of cartilage through the staining of glycosaminoglycans. In addition, Alizarin
red was used to identify calcium containing tissue, allowing for visualization of ossifying
bone (figure 6I/J).
Staining of P0 WT skeletons reveal a fully patterned forelimb. When the
surrounding connective tissue has been cleared, the stylopod, zeugopod, and autopod of
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these mice are all evident. All three forelimb long bones (humerus, ulna, and radius)
consist of a central diaphysis identifiable due to alizarin red staining, flanked by two alcian
blue stain epiphyseal regions consisting of non-ossified cartilage (figure 7). Though
stunted, development of forelimb boney regions does occur in mutants. Skeletal
preparation revealed that a partially formed scapula was present in 100% of mutants
(figure 7A). Articulating to this scapula, all mutant forelimbs possess the most proximal
long bone: the humerus (figure 7B/D). Sequential to the humerus in mutants is what
appears to be a single distal long bone, believed to likely be the ulna (figure 7C/E). The
most distal regions of the limb, primarily the skeletal components of the autopod, appear
to be subject to a high degree of variability in their disruption. While skeletal preparation
revealed that in some mutants carpals, metacarpals, or even stunted phalanges were
formed, precise identification of these structures has yet to be carried out.
To determine the extent to which forelimb skeletal development was impacted by
U11-loss, the long bones of mutant and wild-type littermates were compared based on
three factors: shaft length, diaphysis width, and the extent to which the diaphysis had
begun to ossify (figure 7F). When this analysis was conducted for the humerus, it was
found that U11 loss resulted in a drastic decrease in length of approximately 74% (figure
7). A decrease in diaphysis width was also observed in mutant pups which possessed
widths 0.21mm compared to 0.46mm of wild-type littermates (figure 9). To determine if
the ossification of the humerus had been impacted in mutants due to U11 loss, the extent
to which ossification had occurred was calculated as a percentage of the overall bone
length. It was found that in wild-type humeri, approximately 66% of the total bone had
begun to ossify by P0. However, in mutants there was a drastic decrease of alizarin red
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staining which found that only 33.5% of the cartilage in mutant humeri had begun to ossify
by P0 indicating either disruption or delay of bone formation in these mutants.
Similar analyses were competed for the distal long bones (radius/ulna). However,
due to the extreme variability of developmental defects in the mutant forelimbs, analysis
of these structures was limited. Mutants only possessed at most a single distal long bone.
As such, this structure was compared to both the radius and ulna of wild-type littermates.
The results of these analyses are summarized in figure 9. Despite the variability of this
structure, the decrease in both length and width of the mutant distal long bone was
significant when compared to either wild-type radii or ulnae. When compared to wild-type
littermates, the mutant distal long bone showed a decrease in length of approximately
80% when compared to the ulna or 75% when compared to the radius (figure 7). As with
the humerus, analyses of both diaphysis width and ossification were conducted
comparing the mutant distal long bone to both wild-type ulnae and radii. It was found that
the width of the mutant long bone decreased by 60% when compared to wild-type ulnae,
and 50% for the radii. Meanwhile ossification was reduced by approximately 75% when
compared to both wild-type long bones (figure 9).
The disruption to the hindlimb of mutants is not as drastic as that of the forelimb,
and all skeletal components found in wild-type hindlimbs are present in mutants (figure
8A). In fact, several bone markings which can be observed on wild-type long bones can
be found in the mutants as well. In wild-type femora, bone markings which can be
discerned include the greater trochanter, the third trochanter, and the lateral and medial
condyles (figure 8B). All four of these can also be found in the mutant limbs, making this
the only mutant long bone with identifiable bone markings (figure 8D).
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As with the forelimb, the extent to which loss of U11 has impacted hindlimb bone
growth was determined based on analyses of bone length, width, and ossification
percentage. While changes were not as extreme as in the humerus, mutant femurs were
significantly shorter than those of wild-type litter mates. The overall length of these bones
had decreased from approximately 3.9mm in wild-type pups to 1.9mm in mutants (figure
8). In addition, the diaphysis width had also been reduced by approximately 44% and the
extent of ossification had decreased by 14% (figure 8).
In wild-type mice both the tibia and fibula expected to be relatively close in length
to the femur by P0: approximately 4.1mm and 3.8mm respectively. In mutants it was found
that both of these bones significantly decreased in length with mutant tibiae reaching
approximately 1.4mm and 1.4 for the fibula. A significant decrease in diameter of the
diaphysis of these bones also occurred in mutant mice with the tibia going from 0.48mm
in wild-type mice to no more than 0.22mm in mutants (figure 9). A similar decrease in
width occurs in the mutant fibulae which are approximately 0.17mm in width compared to
0.24mm in wild-type littermates (figure 9). Ossification in both distal long bones of the
hind limb appears to be either disrupted or delayed by P0 as the extent to which calcified
tissue could be stained by alizarin red decreased from 63.8% in wild-type pups to 44.5%
for mutant tibia. The fibulae experienced a similar decrease in ossification; going from
64.1% in wild-type littermates to 43.5% in mutants (figure 9).
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Figure 7. U11 loss results in defects of forelimb patterning and development by P0. A) Comparison of P0
forelimbs of wild-type and U11 cKO littermates. Ossifying boney elements are stained red while unossified
cartilage is stained blue. Arrows mark the developing scapula of both limbs. B/D) The humerus of wild-type mice
is significantly larger than that of U11 cKO mice. Arrows mark the ossifying diaphysis of these developing long
bones. C/E) Unlike wild-type pups which poses two distal long bones, only a single long bone forms in the U11
cKO zeugopod region. Due to its articulation with the humerus, it is believed that this long bone is likely a ulna.
F) Long bone growth was calculated based on three aspects i) total bone length measured from epiphysis to
epiphysis end, ii) Diaphysis width at the center of long bone ossification, and iii) percent of long bone ossification
calculated as length of ossified region/total bone length. As only a single distal long bone was present in mutant
pups, this bone was compared to both the ulna and radius of wild-type littermates. Comparisons of forelimb long
bone length are displayed in graph form. n=3, *p<.05, **p<.005, ***p<.005. Scale bars: A (2.0mm) B-E (1.0mm)
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Figure 8: Loss of U11 results in defects of hindlimb development by P0. A) Comparison of P0
hindlimbs of wild-type and U11 cKO littermates. Ossifying boney elements are stained red while
unossified cartilage is stained blue. B/D) The femur of wild-type mice is significantly larger than that of
U11 cKO mice. Arrows mark the ossifying diaphysis of these developing long bones. C/E) Unlike in the
forelimb, both wild-type and U11 cKO mutants poses two distal long bones. F) As with the forelimb, long
bone growth was calculated based on three aspects i) total bone length measured from epiphysis to
epiphysis end, ii) Diaphysis width at the center of long bone ossification, and iii) percent of long bone
ossification calculated as length of ossified region/total bone length. As only a single distal long bone was
present in mutant pups, this bone was compared to both the ulna and radius of wild-type littermates.
Comparisons of forelimb long bone length are displayed in graph form. n=6, *p<.05, **p<.005, ***p<.005.
Scale bars: A (2.0mm) B-E (1.0mm)
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Figure 9: Summary of Skeletal Comparisons of P0 Limb Development Skeletal Comparison of P0
Hindlimbs. Long bone growth was determined based on 1) Total bone length measured from
epiphysis to epiphysis end, 2) Diaphysis width at the center of long bone ossification, and 3) percent of
long bone ossification calculated as length of ossified region/total bone length. In the hindlimb, shift in
growth defect along the proximodistal axis was determined based on a ratio of proximal long bone length
to that of the distal long bones. Forelimb: n=3. Hindlimb: n=6. *p<.05, **p<.005, ***p<.005
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Loss of U11 Results in Disruption of Proliferating cells through death and
disruption of cell cycle
While skeletal preparations reveal severe limb defects occur in U11 cKO mice by
P0, better understanding of how this phenotype occurs requires investigation of limb
growth during embryonic development. Such disruption could be the result of several
factors, including depletion of the progenitor cell pool early in development or loss of
patterning within the limb. In order to begin understanding which could be the case, I first
investigated the kinetics of U11 expression in wild-type limb buds, as well as U11 loss in
mutant limbs.
In situ hybridization (ISH) was conducted using a U11 RNA probe. By E11 there
appears to be a decrease in U11 expression in mutants when compared to wild-type
littermates in the forelimb (figure 10A). This loss of U11 increases over time and by E12
there appears to be total absence of U11 in the majority of the developing forelimb
mesenchyme. U11 is still present in the overlying ectoderm, which is unaffected by the
Prrx1-cre. At E14, initial patterning of the forelimb is finished in the wild-type mice and
long bones of the forelimbs can be viewed. In wild-type mice, U11 is expressed both in
the connective tissue and in the chondrocyte condensations. However, in the mutant, we
observed a lack of U11 expression in the chondrocyte population of the forelimb, whereas
the connective tissue was U11-positive in some regions. These U11-null condensations
are fated to form the skeletal components of the forelimb and were identified by
expression of Sox9 (Data not shown) (figure 10A). The presence of U11 within
surrounding connective tissue is likely the result of a delay in prrx1 activity.
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In the E11 hindlimb there is little discernable change in U11 expression between
mutant and wild-type mice, likely due to the delayed onset of Prrx1-cre in this region
(figure 10B). However, by E12 there is a noticeable decrease in U11 expression in the
hindlimb mesenchyme of mutant mice (figure 10B). At E14, the hindlimb of wild-type
mice has been completely patterned and U11 expression can be seen in the surrounding
connective tissue of the limb, as well as within the chondrocytes of the long bone itself.
Unlike in the forelimb, by E14 the hindlimb of mutants appears to be patterned similarly
to wild-type mice. However, while U11 can be seen in surrounding connective tissue of
these mutants, the developing long bones lack any U11 expression. This is not the case
for wild-type long bones which are clearly expressing U11 at this time (figure 10B). In
summation, U11 is expressed throughout the limb bud mesenchyme of both the fore- and
hindlimb of wild-type mice at E11. This expression continues through E12, up to E14
where U11 is expressed in both the chondrocytes of the developing long bone, as well as
surrounding connective tissue. In mutant mice is a noticeable decrease of U11 expression
in the E11 forelimb, however, hindlimb loss of U11 does not occur until E12. By E14 the
forelimb has completely lost structural integrity, and U11 is absent in the chondrocyte
populations which would normally contribute to the developing long bones. In the E14
mutant hindlimb long bones have developed, though there is a clear loss of U11
expression in the chondrocyte populations of this region.
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Figure 10: Kinetics of U11 loss in the limb-specific cKO. A) Alkaline phosphatase section in situ staining with U11
riboprobe shows that by E11 there is already a decrease in U11 expression within the forelimb (F) of cKO mutants.
By E12 U11 has been lost entirely from the forelimb mesenchyme of mutants, but is still visible in wild-type
littermates. At E14 chondrocytes (marked with arrows) which have been identified using Sox9 (data not shown) are
still expressing U11 in wild-type forelimbs. However these same cells are completely null for U11 in mutant
forelimbs. B) Similar analyses in the hindlimb (H) show that U11 is still present in the limb mesenchyme through
E11 before dropping drastically by E12. Unlike in the forelimb, bones have patterned in the mutant hindlimb.
However, the chondrocytes in these regions are null for U11, unlike wild-type bones which clearly demonstrate
U11 expression.

36

To determine if the limb phenotypes observed in P0 mutants were the result of a
decrease in the early progenitor cell pool, immunohistochemistry was performed on
cryosections of wild-type and mutant limbs from E11, E12, and E14. To investigate
whether U11 loss could result death of these progenitors, terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) assays were used to visualize any change
in the rate of apoptosis between wild-type and mutant limbs. Ki67 and PH3 were utilized
as markers of cell cycle to investigate if any shifts occurred in proliferating cell
populations. Severe disruption of the mutant forelimb made equivalent comparisons with
wild-type sections inaccurate; therefore analyses were carried out using the less
compromised hindlimb as a model.
When E11 hindlimbs were analyzed, no significant difference was found between
the percentage of TUNEL-positive cells in wild-type or mutant tissue (figure 11A). To
determine if progenitor cells of the developing hindlimb were impacted by U11 loss, Ki67
was used to identify all cells in the cell cycle, and phosphohistone H3 was used as a Mphase specific marker. In E11 wild-type hindlimb buds, almost the entirety (99.7%) of the
total mesenchyme cell population was Ki67-positive (figure 12A). The number of these
cells which are also PH3 positive is much lower (5.6%), indicating that most of the
proliferating limb mesenchyme exists outside of M-phase (figure 12A). In the mutant
hindlimb there appears to be no significant difference between either Ki67 or PH3
expressing cells when compared to wild-type embryos, indicating that at E11 there is no
observable change to the progenitor cell pool in U11 cKO mutants.
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Figure 11. TUNEL assay of U11 cKO shows increased cell death by E14. A) At E11 identification of TUNELpositive cells shows no significant increase of cell death in the hindlimb (H) of U11 cKO mice. TUNEL+ percentages
were calculated as number of TUNEL positive cells over the number of total DAPI stained nuclei per field. B) By
E12 a slight increase in cell death can be detected, however it has not been shown to be statistically significant. C)
In E14 mutant hindlimbs there is a drastic increase in apoptotic cells when compared to wild-type littermates. Scale
bar= 30um. E11 n=3, E12 n=3, E14 n=3. *p<.05, **p<.005, ***p<.005.
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Figure 12: U11cKO show decrease in proliferating cells through Ki67 Staining by E14 A) At E11
immunofluorescent identification of proliferating cells through a combination of Ki67 and PH3 markers shows no
significant change between wild-type and U11 cKO hindlimb (H). B) At E12 a decrease in Ki67-positive cells can
be observed, however at this time the change is not statistically significant. C) By E14 there is a significant decrease
in proliferating cells within the mutant hindlimb. Sox9 identification of differentiating chondrocytes shows no
difference in chondrocyte populations between wild-type and mutant hindlimbs. Scale bar= 30um. E11 n=2, E12
n=3, E14 n=3. *p<.05, **p<.005, ***p<.005
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TUNEL assays conducted at E12 found that while there was an increase in the
number of TUNEL-positive cells in the mutant hindlimb, this difference was not statistically
significant (figure 11B). Similarly, when analyses were conducted for Ki67 at this time
point it was found that while there was a slight decrease in Ki67-positive cells from 99.5%
in wild-type hindlimbs to 99.1% in mutants, this change was not statistically significant.
As with Ki67, comparison of PH3-positive cells in the mutant hindlimb with that of wildtype littermates demonstrated no statistically significant change. (figure 12B).
Unlike at earlier time points, the developing bones of E14 mutants showed an
extensive increase in TUNEL-positivity. In wild-type mice, less than <1% of cells within
the developing long bone were stained by TUNEL assay. However, in mutants this
increased to almost 10% (figure 11C). The number of Ki67-positive cells within the
developing bones also showed a significant change from wild-type values, decreasing
from 32.0% to approximately 20.7% (figure 12C). At this time there is no significant
increase in PH3 expression.
By this time in development, the hindlimb of wild-type mice is fully patterned, and
the cartilaginous condensations which form the scaffolding of future bones consist of a
mixture of proliferating progenitor cells, as well as differentiated chondrocytes. To
determine if differentiation of chondrocytes had been impacted in mutant hindlimbs, Sox9
was used to analyze the chondrocyte population in the epiphyseal regions of the hind
limbs. It was found that in wild-type hindlimbs approximately 56% of the developing bone
was Sox9-positive. In mutants this population composed 58% of cells within the bone
indicating no significant shift in chondrocyte populations within the developing limb
(Figure 12C).
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Discussion
While minor splicing is required for the processing of a relatively small number of
introns (<0.5%), its importance is highlighted by the conservation of this secondary set of
splicing machinery across eukaryotic evolution.15,16 However, while knockout studies in a
wide-range of species have demonstrated the necessity of minor splicing in early
eukaryotic development, it is still unknown what essential role this second spliceosome
plays which has allowed it to persist. The identification of Rnu4atac mutations in MOPDI
and Roifman syndrome patients allows for a correlation to be drawn between minor
splicing and the pathology of these diseases. However, these studies have remained
descriptive in humans, and while it has been shown that MOPDI associated mutations
can decrease efficacy of minor splicing, a causative effect of minor splicing in the
pathogenesis of these diseases has not been found. 1,2
To elucidate what role minor splicing may play in limb development we employed
a limb specific conditional KO of U11. By targeting minor splicing in the developing limb
bud through a non-U4atac dependent manner we were able to induce limb disruption that,
while far more severe than that observed in MOPDI patients, confirms the requirement of
minor splicing in limb development. The extent to which cKO of U11 causes loss of limb
development in mice is drastic, and even between the forelimb and hindlimb there is
variability in the degree of this disruption. While possibly indicating region specificity of
minor splicing requirement, more likely this difference is a result of variability in prrx1-cre
activation between the two limb systems.
Within the forelimb, prrx1-cre recombination occurs as early as E9 and is pervasive
throughout the entirety of the limb bud mesenchyme. However in the hindlimb cre-activity
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is delayed, and even by E10.5 there are regions within the mesenchyme that still do not
express cre.65 It is interesting that this temporal variability could result in such a drastic
change in phenotype, and offers a comparison of how the impact of minor splicing loss
within the limb can be time dependent.
Analysis of the skeletal components of P0 U11 cKO mice reveal that even in the
forelimb, though structural integrity has been almost entirely lost, skeletal elements of all
three limb regions (stylopod, zeugopod, and autopod) are present to varying degrees
(figure 11A). Though the development of these regions has been compromised by U11
cKO, their presence indicates that early patterning if the proximodistal axis has been
successfully laid down in the forelimb. This is confirmed in the hindlimb phenotype where,
though growth has been reduced in the cKO mutants, all skeletal elements are present.
As it appears that initial patterning is not lost due to disruption of minor splicing, a
possible path through which U11 cKO could disturb skeletal development in the limbs is
through reduction of early progenitor cell populations. It is established that proliferation of
limb progenitors is required for limb development. FGFR2 knockout experiments
conducted by Lu et al. have demonstrated that if the AER is not maintained in developing
mouse limbs, it can result in a reduced progenitor population within the limb bud. This
pool, if insufficient, will fail to establish the rudimentary skeletal populations necessary to
generate autopod condensations, resulting in loss of distal limb structures. 66 This type of
proximal to distal bias is reflected in both the forelimb and hindlimbs of U11 ckO mutants
(figure 9). Could U11 loss then be disrupting early progenitor cells? Indeed, work
investigating loss of U11 in the developing brain has already demonstrated that U11 might
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be necessary for maintenance of CNS progenitor cells.25 We therefore investigated how
loss of minor splicing could affect progenitor cells in the limb.
One such impact which might occur would be a decrease in the population of limb
progenitors through increased cell death. In situ analysis of the kinetics of U11 loss in the
mutant hindlimb reveals that knockout of U11 from the limb bud mesenchyme does not
occur until around E12 (figure 10). Therefore, it is unlikely that any significant change in
the mutant progenitor survival would occur before that time. Indeed, no significant
increase in TUNEL-positivity was detected in U11 cKO mouse hindlimbs prior to E12.
However, by E14 the number of dying cells in the developing mutant bones does increase
significantly between wild-type and mutants (figure 11). This would indicate that an
increase in apoptosis could possibly contribute to the skeletal defects observed at P0.
However, the percentage of dying cells within the developing bones, even at E14, is
relatively small. Therefore it is unlikely that cell death alone constitutes a loss of progenitor
cells impactful enough to result in the phenotype observed.
As cell death alone is likely not the sole driving force behind the disruption of
mutant long bone growth, we next looked to how the proliferating progenitors of the limb
were altered due to U11 loss. Using Ki67 and Ph3 to mark proliferating cells it was found
that at E11 there is no difference between wild-type and mutant hindlimb mesenchyme
proliferation. However, this begins to change as U11 is lost, and by E12 there is a slight
(though not yet statistically significant) decrease in Ki67-positive cells in the mutants. At
E14 this shift in progenitors out of cell cycle is even more pronounced, as there is a 42%
decrease in the number of proliferating cells between wild-type and mutant embryos.
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This loss of proliferating cells could be attributed to two possible factors. First it
could result from an increased exit of progenitor cells from cell cycle. Alternatively,
increased differentiation of progenitors to chondrocytes might be reflected in a shift away
from proliferation. Marking of cells with Sox9 shows no significance change between wildtype and mutant mice in the percentages of differentiating chondrocytes. This in turn
indicates that though loss of U11 does decrease the number of cells in cell cycle, it does
not appear to shift the percentage of differentiating cells.
How then do these results explain the severe phenotype we see by P0? It is likely
that loss of minor splicing specifically impacts the proliferating mesenchyme of the early
limb bud, depleting this central pool of progenitors through a combination of cell-cycle exit
and death. Initial patterning of the proximodistal axis of the mouse limb is unaffected by
U11 loss, as evidenced by the proper patterning of all skeletal elements of the U11 cKO
hindlimb as well as the presence of at least some distal structures in the mutant forelimb.
The presence of such structures is indicative of successful early patterning of progenitor
populations as suggested by the early differentiation front model of limb development. 53
Therefore, loss of proliferating progenitors appears the most likely cause
developmental defects observed in U11 cKO limbs.
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Conclusion and Future Directions
My results reveal that minor splicing is essential for limb development in mice, and
that loss of this cellular process likely impacts proliferating progenitor cells early in
development. It has been well established that minor splicing is essential for development
in eukaryotes.1-5 Yet while mutations resulting in MOPD and Roifman syndrome have led
to a correlation between minor splicing and limb development, this is the first known
instance of utilizing direct loss of a minor splicing component to investigate limb
development in mice. Using this model we have demonstrated that loss of U11 causes a
decrease in the number of proliferating cells within the developing mouse limb due to a
combination of cell death and an exiting of cells from cell cycle. This reduction in
proliferating progenitors in turn results in severe disruption of limb growth by P0.
While it is likely that U11 is necessary for maintenance of progenitors within the
developing mouse limb, it also is possible that the phenotype observed in U11 cKO mice
could be the result of a loss of limb patterning through indirect influence on the signaling
centers within the limb. Several regions within the limb must communicate for limb growth
and patterning to occur. The AER and ZPA in particular are essential in not only patterning
the limb’s proximal-distal and anterior-posterior axes, but also in the maintenance of one
another through the SHH-GREM1-FGF feedback loop. Prrx1-cre is not expressed in the
AER, therefore making it unlikely that U11 loss is impacting this region directly. 65
However, by disturbing the mesenchyme required for relaying SHH signaling through
GREM1 activity, it might be possible that U11 loss is indirectly leading to disturbance of
the feedback loop necessary for maintenance of the AER. Indeed, preliminary data has
suggested that in U11cKO mutants, there might be an increased percentage of dying
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cells within the presumptive AER, despite continued U11 expression (data not shown).
To confirm whether U11 cKO mutants are experiencing patterning disruption though such
a pathway, further work should be conducted focusing on both the impact of U11 loss on
limb signaling centers, and at the underlying molecular shifts occurring due to U11 cKO.
One path of continuing investigation could be employment of whole-mount In situ
hybridization to determine if there is a shift in the expression of essential signaling
molecules including FGFs, SHH, BMPs, and GREM1 within the U11 cKO limbs.
Additionally, further analysis of molecular changes within the mutant limbs could be
examined through the use of RNA sequencing. Such an analysis has already been
conducted in U11-null tissue of the developing mouse CNS.25 This study demonstrated
that cKO of U11 resulted in differentiating expression of MIGs linked to many different
cellular processes. Among those impacted were systems required for cell cycle and cell
survivability. If a similar shift in MIG expression is found in our limb-specific U11 cKO, this
could credence to the role of minor splicing In maintaining proliferation of progenitors in
the developing limb bud.
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